Страна: Австралия
Язык: английский
Источник: Department of Health (Therapeutic Goods Administration)
caspofungin acetate, Quantity: 77.69 mg (Equivalent: caspofungin, Qty 70 mg)
Cipla Australia Pty Ltd
Injection, powder for
Excipient Ingredients: sucrose; mannitol; glacial acetic acid; sodium hydroxide
Intravenous
CASPOFUNGIN CA is indicated for: ? Empirical therapy for presumed fungal infections in febrile, neutropenic patients whose fever has failed to respond to broad-spectrum antibiotics ? Treatment of: - Invasive Candidiasis, including candidaemia - Oesophageal Candidiasis - Invasive Aspergillosis in patients who are refractory to or intolerant of other therapies
Visual Identification: White to off white powder or cake; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store at 2 to 8 degrees Celsius
Registered
2018-01-12